MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-450-18 |
Device Problem
Detachment of Device or Device Component (2907)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/28/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that, during deployment, it was noticed that the tip coil had gone down through the stent due to hypotube detachment proximal to the wire weld.The broken segment was removed from the patient together with the catheters.The pipeline was then replaced and the procedure completed successfully.The patient was undergoing treatment of a ruptured, saccular right ica periopthalmic artery aneurysm with a max diameter of 6mm and a neck width of 4mm.The devices were prepared as indicated per the ifu, and the patient's vessel tortuosity was noted to be severe.There were no related patient symptoms.Dual antiplatelet treatment was administered.Post procedure angiographic results were good.
|
|
Event Description
|
Additional information received reported that the cause of the pushwire break was not determined.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3: analysis of the pipeline flex embolization device (lot no.A748942) found that the pipeline flex pusher was protruding from within the marksman catheter hub for ~36.6 cm.The marksman catheter body was found accordioned from ~9.0 cm to ~4.5 cm from the distal tip.No damage was found with the marksman distal tip.The pipeline flex braid and tip coil were found partially deployed out from within the marksman distal tip.The pipeline flex embolization device was pushed out from the marksman distal tip, fully deploying the braid.No bends, kinks, or separations were found with the pipeline flex pusher.The pipeline flex braid ends were found open, but damaged (frayed).No other anomalies were observed.Based on the device analysis and reported information, the customer¿s report of ¿pushwire detach at hypotube proximal to the wire weld¿ could not be confirmed as no breaks or separations were found with the returned pipeline flex embolization device.The pipeline flex braid and phenom 27 catheter body were found damaged.It is possible the patient¿s ¿severe¿ vessel tortuosity contributed to the damages.However, the cause for the damage could not be determined.H6: method code updated to b01.Result code updated to c070601.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
No additional information received.
|
|
Search Alerts/Recalls
|
|
|